Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 12,228,465 | 12,480,000 | +251,535 | $141.12M | $147.64M | 55.22% | +$6.52M |
| Liquidia Corporation(LQDA) | 7,182,532 | 1,860,371 | -5,322,161 | $71.83M | $21.88M | 8.18% | -$49.95M |
| Insmed Incorporated(INSM) | 171,704 | 307,167 | +135,463 | $12.53M | $21.21M | 7.93% | +$8.67M |
| Cullinan Therapeutics, Inc.(CGEM) | 824,705 | 878,897 | +54,192 | $13.81M | $10.70M | 4.00% | -$3.10M |
| EyePoint, Inc.(EYPT) | 1,361,979 | 1,410,331 | +48,352 | $10.88M | $10.51M | 3.93% | -$375.2K |
| Nurix Therapeutics, Inc.(NRIX) | 325,789 | 446,296 | +120,507 | $7.32M | $8.41M | 3.14% | +$1.09M |
| Intra-Cellular Therapies Inc. | 0 | 71,990 | +71,990 | $0 | $6.01M | 2.25% | +$6.01M |
| Enliven Therapeutics Inc | 90,572 | 224,038 | +133,466 | $2.31M | $5.04M | 1.89% | +$2.73M |
| Geron Corporation(GERN) | 0 | 1,321,268 | +1,321,268 | $0 | $4.68M | 1.75% | +$4.68M |
| Ocular Therapeutix, Inc.(OCUL) | 235,498 | 470,919 | +235,421 | $2.05M | $4.02M | 1.50% | +$1.97M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 121,732 | +121,732 | $0 | $4.00M | 1.50% | +$4.00M |
| Pharvaris N V COM | 242,341 | 207,603 | -34,738 | $4.49M | $3.98M | 1.49% | -$508.4K |
| Disc Medicine, Inc.(IRON) | 0 | 56,400 | +56,400 | $0 | $3.58M | 1.34% | +$3.58M |
| Springworks Therapeutics, Inc. | 0 | 93,137 | +93,137 | $0 | $3.37M | 1.26% | +$3.37M |
| Allogene Therapeutics, Inc. | 0 | 1,489,909 | +1,489,909 | $0 | $3.17M | 1.19% | +$3.17M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 64,900 | +64,900 | $0 | $2.68M | 1.00% | +$2.68M |
| Intellia Therapeutics, Inc.(NTLA) | 128,569 | 215,981 | +87,412 | $2.64M | $2.52M | 0.94% | -$123.8K |
| Arvinas, Inc.(ARVN) | 0 | 86,627 | +86,627 | $0 | $1.66M | 0.62% | +$1.66M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 32,000 | +32,000 | $0 | $1.38M | 0.52% | +$1.38M |
| Astria Therapeutics Inc | 39,422 | 105,057 | +65,635 | $434.0K | $939.2K | 0.35% | +$505.2K |